RU2018126368A - Композиция для уменьшения частоты мочеиспускания, способ ее получения и применение - Google Patents
Композиция для уменьшения частоты мочеиспускания, способ ее получения и применение Download PDFInfo
- Publication number
- RU2018126368A RU2018126368A RU2018126368A RU2018126368A RU2018126368A RU 2018126368 A RU2018126368 A RU 2018126368A RU 2018126368 A RU2018126368 A RU 2018126368A RU 2018126368 A RU2018126368 A RU 2018126368A RU 2018126368 A RU2018126368 A RU 2018126368A
- Authority
- RU
- Russia
- Prior art keywords
- prostaglandin
- inhibitor
- release
- pharmaceutical composition
- component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/975,332 US10105328B2 (en) | 2014-06-06 | 2015-12-18 | Composition for reducing frequency of urination, method of making and use thereof |
| US14/975,332 | 2015-12-18 | ||
| PCT/US2016/065775 WO2017106032A1 (fr) | 2015-12-18 | 2016-12-09 | Composition pour réduire la fréquence de la miction, son procédé de fabrication et d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018126368A true RU2018126368A (ru) | 2020-01-20 |
Family
ID=59057330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018126368A RU2018126368A (ru) | 2015-12-18 | 2016-12-09 | Композиция для уменьшения частоты мочеиспускания, способ ее получения и применение |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP3389661A4 (fr) |
| JP (1) | JP2018538310A (fr) |
| KR (1) | KR20180101403A (fr) |
| CN (1) | CN108601782A (fr) |
| AU (1) | AU2016370313A1 (fr) |
| BR (1) | BR112018012030A2 (fr) |
| CA (1) | CA3008628A1 (fr) |
| IL (1) | IL259974A (fr) |
| MX (1) | MX2018007326A (fr) |
| RU (1) | RU2018126368A (fr) |
| SG (1) | SG11201806001TA (fr) |
| TW (1) | TW201726115A (fr) |
| WO (1) | WO2017106032A1 (fr) |
| ZA (1) | ZA201804749B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7499027B2 (ja) * | 2019-12-27 | 2024-06-13 | 小林製薬株式会社 | 内服用医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
| GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
| TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| US20160074397A1 (en) * | 2013-03-13 | 2016-03-17 | Wellesley Pharmaceuticals, Llc | Composition for reducing frequency of urination, method of making and use thereof |
| AU2014396189A1 (en) * | 2014-06-06 | 2016-12-22 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| JP2018529711A (ja) * | 2015-09-30 | 2018-10-11 | ウェルズリー ファーマスーティカルズ、エルエルシー | 排尿の頻度を低減するための組成物、ならびにその作製および使用方法 |
-
2016
- 2016-12-09 RU RU2018126368A patent/RU2018126368A/ru not_active Application Discontinuation
- 2016-12-09 CA CA3008628A patent/CA3008628A1/fr not_active Abandoned
- 2016-12-09 WO PCT/US2016/065775 patent/WO2017106032A1/fr not_active Ceased
- 2016-12-09 EP EP16876420.7A patent/EP3389661A4/fr not_active Withdrawn
- 2016-12-09 KR KR1020187020547A patent/KR20180101403A/ko not_active Withdrawn
- 2016-12-09 CN CN201680080714.5A patent/CN108601782A/zh active Pending
- 2016-12-09 MX MX2018007326A patent/MX2018007326A/es unknown
- 2016-12-09 AU AU2016370313A patent/AU2016370313A1/en not_active Abandoned
- 2016-12-09 JP JP2018532044A patent/JP2018538310A/ja active Pending
- 2016-12-09 SG SG11201806001TA patent/SG11201806001TA/en unknown
- 2016-12-09 BR BR112018012030A patent/BR112018012030A2/pt not_active Application Discontinuation
- 2016-12-15 TW TW105141599A patent/TW201726115A/zh unknown
-
2018
- 2018-06-12 IL IL259974A patent/IL259974A/en unknown
- 2018-07-16 ZA ZA2018/04749A patent/ZA201804749B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3389661A1 (fr) | 2018-10-24 |
| BR112018012030A2 (pt) | 2018-12-04 |
| CN108601782A (zh) | 2018-09-28 |
| SG11201806001TA (en) | 2018-08-30 |
| MX2018007326A (es) | 2019-03-28 |
| WO2017106032A1 (fr) | 2017-06-22 |
| IL259974A (en) | 2018-07-31 |
| ZA201804749B (en) | 2019-09-25 |
| TW201726115A (zh) | 2017-08-01 |
| CA3008628A1 (fr) | 2017-06-22 |
| EP3389661A4 (fr) | 2019-12-18 |
| AU2016370313A1 (en) | 2018-07-26 |
| KR20180101403A (ko) | 2018-09-12 |
| JP2018538310A (ja) | 2018-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Altman et al. | Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology | |
| RU2014145557A (ru) | Комбинированный состав, содержащий многокомпонентную сфероидальную таблетку (мкст), заключенную в твердую капсулу, и способ его приготовления | |
| ZA200810125B (en) | Pharmaceutical combination comprising 3- (3-dimethy-lamin0-1-ethyl-2-methyl-pr0pyl)-phenol and an NSAID | |
| JP2009541443A5 (fr) | ||
| NO20072257L (no) | Nye tablettformuleringer med modifisert frigivning for protonpumpeinhibitorer | |
| BRPI0606883A2 (pt) | composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única | |
| HRP20171743T1 (hr) | Sastavi i postupci za savladavanje otpornosti na tramadol | |
| PL191966B1 (pl) | Farmaceutyczna postać jednostkowego dawkowania zawierająca przeciwbólowe połaczenie inhibitora COX-2 i oksykodonu lub morfiny, oraz zastosowanie inhibitora COX-2 i oksykodonu lub morfiny | |
| AR089645A1 (es) | Particula multicapas de sabor enmascarado, metodo, uso, composicion farmaceutica | |
| JP2012520883A5 (fr) | ||
| RU2016133305A (ru) | Состав с длительным высвобождением для снижения частоты мочеиспускания и способ его применения | |
| JP2013517304A5 (fr) | ||
| WO2011140446A3 (fr) | Formulations pharmaceutiques | |
| RU2014129508A (ru) | Новая комбинация | |
| HRP20161340T1 (hr) | Formulacije darunavira | |
| WO2007143163A3 (fr) | Compositions pharmaceutiques pour la libération prolongée de phenylephrine | |
| AR078951A1 (es) | Esferoides de farmacos revestidos y usos de los mismos para la eliminacion o reduccion de afecciones tales como emesis y diarrea | |
| JP2012082195A5 (fr) | ||
| RU2015106672A (ru) | Фармацевтическая композиция для уменьшения частоты мочеиспускания и способ ее применения | |
| RU2015138784A (ru) | Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов | |
| RU2018126368A (ru) | Композиция для уменьшения частоты мочеиспускания, способ ее получения и применение | |
| TR201906158T4 (tr) | Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar. | |
| AR061165A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
| JP2015522659A5 (fr) | ||
| RU2018111400A (ru) | Препарат пролонгированного, отсроченного и немедленного высвобождения, способ его получения и применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20191210 |